Abacus Insights offers a data management solution that standardizes data across the healthcare ecosystem by providing a highly secure unified data infrastructure that minimizes change management and maximizes analytics enablement to help healthcare providers improve costs and member outcomes for customers. Abacus Insights delivers intelligent data management capabilities for actionable insights. It was founded in 2017 and headquartered in New York City.
CirrusMD is a text-first enterprise solution that connects people and doctors with no-barriers access to human experts who can always help. It develops a solution to deliver guidance beyond primary care. The company was founded in 2012 and is headquartered in Denver, Colorado.
Drips.com features an AI engine that helps improve lead-to-call conversion and reduces overall lead gen costs. Its solutions allow its users to increase or decrease lead flow, via Conversational text messaging without having to hire or fire agents or worry about space constraints. The company was founded in 2014 and headquartered in Ohio, United States.
Emids is a provider of digital transformation solutions to the healthcare industry, serving payers, providers, life sciences, and technology firms. Headquartered in Nashville, emids helps bridge critical gaps in providing accessible, affordable, and high-quality healthcare by providing digital transformation services, custom application development, data engineering, business intelligence solutions, and specialized consulting services to all parts of the healthcare ecosystem.
HeartFlow focuses on precision heart care, combining human ingenuity with technology. HeartFlow’s non-invasive HeartFlow FFRCT Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRCT Analysis is commercially available in the United States, UK, Canada, Europe, and Japan.
Headquartered in Kennewick, Washington, Ideal Option has delivered personalized medicine to over 20,000 patients through a network of 60 urban and rural office-based opioid treatment (“OBOT”) clinics across 10 states. Ideal Option emphasizes individualized treatment programs for patients consisting of MAT and behavioral counseling services to drive superior outcomes. The Company extensively utilizes telemedicine technology to reach secondary and tertiary markets where access to treatment is limited or non-existent. Ideal Option and its team of over 90 medical providers are dedicated to delivering excellent patient care with integrity and empathy.